
Medivizor wins mobile health startup contest
Free Israeli website allows patients with serious and chronic illness to get cutting-edge, reliable health information.

Free Israeli website allows patients with serious and chronic illness to get cutting-edge, reliable health information.
BGU professor wins Bill & Melinda Gates grant to continue his years-long fight to wipe out parasitic infections in Ethiopia.

Israeli expert is experimenting with intestinal parasites to fight conditions such as rheumatoid arthritis and Crohn’s disease.

Israeli study finds asthmatics with vitamin D deficiency are significantly more likely to experience acute attacks.

Intel’s advanced analytics team in Israel built the heart of a new device to collect, analyze and transmit a wealth of symptom data to reveal new insights.

Telesofia enables customized instructional videos on surgery, treatment, lab results, medication usage, discharge instructions and home care.

Israeli research team develops a special MRI procedure for visualizing damage to the blood-brain barrier.

An Israeli scientist has developed a promising antibody therapy that could one day cure ebola.

Study finds a more stimulating environment helped lab mice rehabilitate faster following traumatic brain injury.

An implantable bio-artificial pancreas developed in Israel is going into clinical trials to determine if its unique features provide the key to a cure.

New Weizmann Institute study shows olfactory conditioning while you sleep can change your behavior and help with addictions.

A first-in-class pocket-sized metered-dose cannabis inhaler helps patients and doctors control, monitor and fine-tune dosages.

The novel Pneumonitor device alerts nurses well before ventilated preterm newborns go into respiratory distress.

Two promising Israeli treatments target common conditions affecting millions of men across the world.

A significant study by Israeli, American and Swedish researchers pins the blame for type 1 diabetes on a virus contracted by mothers during pregnancy.